Literature DB >> 1083377

Synthesis and release of polyribophosphate by Haemophilus influenzae type b in vitro.

P Anderson, J Pitt, D H Smith.   

Abstract

Polyribophosphate, the capsular polysaccharide antigen of Haemophilus influenzae type b, can be assayed in crude bacterial extracts by a combination of immunoprecipitation, hot-acid extraction, and colorimetry. In vitro, the antigen is synthesized during growth and, in well-buffered media, in early stationary phase as well. It is shed from the cell throughout the course of synthesis, and at 37 C almost all the extractable antigen has been released spontaneously within several hours after synthesis. Various strains are similar in extent of synthesis and gross composition of the antigen; however, strains differ in the rate of release during exponential phase. The antigen is released as (or as part of) a very large structure, although under certain culture conditions much smaller antigenic units are found.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083377      PMCID: PMC420649          DOI: 10.1128/iai.13.2.581-589.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Polyribophosphate, the type-specific substance of Hemophilus influenzae, type b.

Authors:  S ZAMENHOF; G LEIDY; P L FITZGERALD; H E ALEXANDER; E CHARGAFF
Journal:  J Biol Chem       Date:  1953-08       Impact factor: 5.157

2.  Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.

Authors:  D H Smith; G Peter; D L Ingram; A L Harding; P Anderson
Journal:  Pediatrics       Date:  1973-11       Impact factor: 7.124

Review 3.  Bacterial exopolysaccharides.

Authors:  I W Sutherland
Journal:  Adv Microb Physiol       Date:  1972       Impact factor: 3.517

4.  Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies.

Authors:  J B Robbins; J C Parke; R Schneerson; J K Whisnant
Journal:  Pediatr Res       Date:  1973-03       Impact factor: 3.756

5.  Polyribitol-phosphate: an antigen of four gram-positive bacteria cross-reactive with the capsular polysaccharide of haemophilus influenzae type B.

Authors:  M Argaman; T Y Liu; J B Robbins
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

6.  Immunity to Hemophilus influenzae type b. I. The isolation, and some physicochemical, serologic and biologic properties of the capsular polysaccharide of Hemophilus influenzae type b.

Authors:  L P Rodrigues; R Schneerson; J B Robbins
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

7.  Capsular polymer of Haemophilus influenzae, type b. I. Structural characterization of the capsular polymer of strain Eagan.

Authors:  R M Crisel; R S Baker; D E Dorman
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

8.  Human serum activities against Hemophilus influenzae, type b.

Authors:  P Anderson; R B Johnston; D H Smith
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

9.  Synthesis of type III pneumococcal polysaccharide by suspensions of resting cells.

Authors:  A W BERNHEIMER
Journal:  J Exp Med       Date:  1953-05       Impact factor: 14.307

  9 in total
  11 in total

1.  Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b.

Authors:  P Anderson; D H Smith
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

2.  Comparison of two antigen detection techniques in a primate model of Haemophilus influenzae type b infection.

Authors:  D W Scheifele; R S Daum; V P Syriopoulou; G R Siber; A L Smith
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

3.  Use of bexB to detect the capsule locus in Haemophilus influenzae.

Authors:  Gregg S Davis; Sara A Sandstedt; Mayuri Patel; Carl F Marrs; Janet R Gilsdorf
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

4.  Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.

Authors:  S C Szu; A L Stone; J D Robbins; R Schneerson; J B Robbins
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

5.  Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

6.  Immunogenic proteins in cell-free culture supernatants of Haemophilus influenzae type b.

Authors:  P A Gulig; G H McCracken; P L Holmans; E J Hansen
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

7.  Pathophysiology of hemolysis in infections with Hemophilus influenzae type b.

Authors:  S B Shurin; P Anderson; J Zollinger; R K Rathbun
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

8.  Minimum number of bacteria needed for antigen detection by counterimmunoelectrophoresis: in vivo and in vitro studies.

Authors:  J C Fung; K Wicher
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

9.  Effect of heat on antigenicity and immunogenicity of the antigenic determinant shared by Haemophilus influenzae type b and Escherichia coli K100.

Authors:  H Y Whang; J Goldhar; E Neter
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

10.  Simplified procedure for preparation of sensitized latex particles to detect capsular polysaccharides: application to typing and diagnosis of Actinobacillus pleuropneumoniae.

Authors:  T J Inzana
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.